Improving how fat cells store fat to lower risk of diabetes and fatty liver
Mechanistic Connection between Interorganellar Communication and Obesity-associated Diseases
This work looks at a fat-cell protein called CLSTN3B to understand how it helps fat cells hold onto fat and how that could affect people with obesity and related conditions like type 2 diabetes and fatty liver.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11292882 on NIH RePORTER |
What this research studies
Researchers are studying a protein made in white fat cells that seems to help the little fat droplets inside cells stay stable and store fat properly. They use mouse models that lack or overproduce CLSTN3B and lab experiments on cells and tissues to see how the protein changes fat droplet structure and fat handling. By linking those molecular changes to whole-body metabolism in animals, the team wants to learn why some people with obesity develop diabetes or fatty liver while others do not. Understanding this process could point toward new ways to protect organs from excess fat.
Who could benefit from this research
Good fit: Adults with obesity or early type 2 diabetes or nonalcoholic fatty liver disease who are interested in contributing to research or future clinical studies would be the most relevant patient group.
Not a fit: People with conditions unrelated to adipocyte lipid storage (for example, type 1 autoimmune diabetes or genetic lipodystrophies) are less likely to benefit from findings about this specific fat-cell protein.
Why it matters
Potential benefit: If successful, this research could point to new drug targets or strategies to help fat cells store fat safely and reduce the risk of type 2 diabetes, nonalcoholic fatty liver disease, and heart problems.
How similar studies have performed: Early animal and lab studies provide preliminary evidence that CLSTN3B affects fat storage, but translating these findings to human treatments is still untested and exploratory.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Zeng, Xing — Ut Southwestern Medical Center
- Study coordinator: Zeng, Xing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.